299912-59-7 Usage
Uses
Used in Pharmaceutical Research and Development:
Erlotinib iMpurity 2 is used as an intermediate or reference standard for the research and development of pharmaceutical formulations. It aids in the identification, characterization, and quantification of Erlotinib and its metabolites, ensuring the quality and efficacy of the drug.
Used in Quality Control and Analysis:
Erlotinib iMpurity 2 is employed as a reference standard in quality control and analysis processes. It helps in assessing the purity and potency of Erlotinib, ensuring that the drug meets the required standards for safety and efficacy.
Used in Metabolite Identification and Characterization:
As a potential metabolite of Erlotinib, Erlotinib iMpurity 2 is used for the identification and characterization of metabolites in biological samples. This information is crucial for understanding the drug's metabolism, pharmacokinetics, and potential side effects.
Used in Drug Development and Optimization:
Erlotinib iMpurity 2 plays a role in drug development and optimization processes. By studying its properties and interactions with Erlotinib, researchers can gain insights into the drug's mechanism of action, potential improvements, and the development of new therapeutic agents.
Used in Regulatory Compliance:
Erlotinib iMpurity 2 is used to ensure regulatory compliance in the pharmaceutical industry. Its proper handling, storage, and disposal are regulated by guidelines and regulations to maintain safety and environmental standards.
Check Digit Verification of cas no
The CAS Registry Mumber 299912-59-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,9,9,1 and 2 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 299912-59:
(8*2)+(7*9)+(6*9)+(5*9)+(4*1)+(3*2)+(2*5)+(1*9)=207
207 % 10 = 7
So 299912-59-7 is a valid CAS Registry Number.
299912-59-7Relevant articles and documents
New method for the preparation of erlotinib
-
Page/Page column 11, (2012/04/10)
The present invention refers to an alternative method for the preparation of Erlotinib through a new chemical reaction for the preparation of the 4-(3-aminophenyl)-2-methyl-3-butyn-2-ol key intermediate of formula (IV) according to the following scheme.
METHOD FOR THE PREPARATION OF ERLOTINIB
-
Page/Page column 7-8, (2012/04/23)
An alternative method for the preparation of Erlotinib through a new chemical reaction for the preparation of the 4-(3-aminophenyl)-2-methyl-3-butyn-2-ol key intermediate of formula (IV) according to the following scheme.